GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FDPS, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
11.7475 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, IGF1R, MAOB, MMP2, MMP9, PPARA, PTGES, RELA, SRC, TYR |
11.3778 |
[BP] GO:0008152 |
metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
10.8679 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, MAOB, PTGES, RELA, SRC, TYR |
9.96712 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, MAOB, MMP2, PPARA, PTGES, RELA, SRC, TYR |
9.38604 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES |
9.38604 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
9.1856 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, HSD11B2, MAOB, PTGES, RELA, SRC, TYR |
9.03122 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FDPS, FUT7, GBA2, GLO1, HMGCR, HSD17B3, PDE5A, PIM1, PPARA, PTGES, TYR, XDH |
8.62931 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MAOB, MMP9, PTGES, RELA, SRC |
8.08392 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CYP19A1, CYP1A1, CYP1B1, ESR1, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAOB, MET, PPARA, SRC, TNKS, TNKS2, XDH |
7.95756 |
[BP] GO:0032502 |
developmental process
|
ACHE, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD17B2, HSD17B3, KDR, MAOB, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, RELA, SRC, TNKS2, TOP2A, TYR |
7.95756 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
7.95756 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, MAOB, MMP2, MMP9, PPARA, PTGES, RELA, SRC, TYR |
7.95756 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, MAOB, PPARA, RELA, SRC |
7.92808 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MAOB, MMP2, PPARA, RELA, SRC |
7.79269 |
[BP] GO:0010941 |
regulation of cell death
|
AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TOP2A, XDH |
7.63319 |
[BP] GO:0010647 |
positive regulation of cell communication
|
AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
7.61119 |
[BP] GO:0023056 |
positive regulation of signaling
|
AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F3, FLT3, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
7.58857 |
[BP] GO:0043067 |
regulation of programmed cell death
|
AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
7.57566 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
7.49355 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
7.39372 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.11555 |
[BP] GO:0042127 |
regulation of cell proliferation
|
AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MMP2, MMP9, PDE5A, PIM1, PTGES, RELA, SRC, XDH |
6.98267 |
[BP] GO:0042981 |
regulation of apoptotic process
|
AKR1B1, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTPN1, RELA, SRC, TOP2A, XDH |
6.93495 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, FDPS, GBA2, HMGCR, HSD17B3, MAOA, MAOB, TYR |
6.90787 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.90787 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, MAOB, TYR, XDH |
6.88686 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.56749 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
6.50879 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, SRC |
6.4815 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
6.4815 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.47047 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.01656 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.90763 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.86932 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.68677 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
5.67225 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CYP1B1, F3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MET, PDE5A, PTPN1, RELA, SRC, XDH |
5.57819 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, F3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
5.54007 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, MAOB, MAP2K1, MMP9, PIM1, PPARA, RELA, SRC, TYR |
5.46509 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, HMGCR, KDR, MAOB, RELA, SRC |
5.17306 |
[BP] GO:0060548 |
negative regulation of cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
4.98889 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.98889 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FDPS, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTPN1, SRC, TNKS, XDH |
4.94373 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, XDH |
4.89299 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F3, FLT3, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.89299 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HMGCR, HSD11B2, KDR, MAOB, RELA, SRC |
4.89299 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F3, FABP4, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.77553 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, RELA, SRC |
4.77553 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MMP2, MMP9, PIM1, RELA |
4.68599 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PTGES |
4.68599 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.64785 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FDPS, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTPN1, SRC, TNKS, XDH |
4.64019 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, MAOB, RELA, SRC |
4.61895 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MET, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.61895 |
[BP] GO:0032844 |
regulation of homeostatic process
|
AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, HCAR2, HMGCR, KDR, SRC, TNKS, TNKS2 |
4.5204 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, RELA, SRC |
4.49775 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
4.49775 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MMP2, MMP9, PTPN1, RELA, SRC, TOP2A |
4.46044 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RELA, SRC |
4.41565 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.41565 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HMGCR, HSD17B3 |
4.36014 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.36014 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.36014 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, SRC, TOP2A |
4.36014 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, RELA, SRC |
4.35566 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
4.32529 |
[BP] GO:0032501 |
multicellular organismal process
|
AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, RELA, SRC, TNKS2, TYR |
4.32166 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FDPS, FUT7, GBA2, HMGCR, MET, PPARA, PTGES |
4.28772 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.23699 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, HMGCR, IGF1R, KDR, MMP9, PIM1, PTPN1, RELA, SRC |
4.19801 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MET, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
4.11091 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
4.03178 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
3.95783 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, SRC, TOP2A, TYR |
3.93925 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
3.79025 |
[BP] GO:0009056 |
catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MAOA, MAOB, MMP1, MMP2, MMP9, PDE5A, SRC, XDH |
3.68752 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, RELA, SRC |
3.60617 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, SRC |
3.57745 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
3.57745 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
APP, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
3.57745 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51502 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.51502 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
APP, AR, BCL2, CDC25B, ESRRB, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
3.46592 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
APP, AR, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC, XDH |
3.44365 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, MAOB, MMP9, PTGES |
3.41986 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, APEX1, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1B1, F3, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MET, MMP9, PPARA, PTPN1, SRC |
3.40559 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.37873 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CDK6, CYP1B1, ESR1, IGF1R, MMP2, MMP9, RELA, SRC |
3.36493 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.36493 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.35522 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.33343 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, MAP2K1, MET, PIM1, SRC, TYR |
3.25853 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, MAOB, RELA, SRC |
3.23479 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.21723 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
3.19417 |
[BP] GO:0048583 |
regulation of response to stimulus
|
AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, PDE5A, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
3.19417 |
[BP] GO:0042325 |
regulation of phosphorylation
|
APP, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
3.19277 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, HSD11B2, IGF1R, PPARA, RELA, SRC |
3.17619 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, ESR1, FLT3, SRC |
3.15932 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
3.14415 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.14208 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.09951 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.08763 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
APP, AR, BCL2, CDC25B, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
3.07306 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS, HMGCR |
3.05752 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, RELA, SRC |
3.03755 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
3.01218 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, MAOB, PTGES, RELA, SRC |
3.01218 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.97208 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
2.96741 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KDR, RELA, SRC |
2.96741 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CDK6, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HMGCR, KDR, MAP2K1, MET, MMP2, MMP9, SRC, TOP2A |
2.95995 |
[BP] GO:0044093 |
positive regulation of molecular function
|
APP, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, XDH |
2.95103 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
APP, AR, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PPARA, PTPN1, SRC, XDH |
2.92887 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
APP, AR, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC, XDH |
2.92879 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.9136 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, MAOA, MAOB, TYR |
2.90641 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, HCAR2, HMGCR, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, RELA, SRC, TNKS2, XDH |
2.88497 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.85055 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, MAOB, PTGES, RELA, SRC |
2.84291 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
APP, AR, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, RELA, SRC, XDH |
2.82721 |
[BP] GO:0080134 |
regulation of response to stress
|
APP, CDK6, CYP19A1, ESR1, F3, FABP4, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, MMP2, PPARA, PTPN1, RELA, SRC, XDH |
2.81012 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.80133 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, HMGCR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
2.79096 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.7903 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TNKS, TOP2A |
2.7903 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.78925 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.7826 |
[BP] GO:0044092 |
negative regulation of molecular function
|
APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.78017 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, ESR1, IGF1R, KDR, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.76417 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, FUT7, GBA2, GLO1, HMGCR, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.76417 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, HMGCR, IGF1R, MET, MMP9, PTPN1, RELA, SRC, XDH |
2.74084 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, RELA, SRC, TYR |
2.73569 |
[BP] GO:0051270 |
regulation of cellular component movement
|
APEX1, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.73569 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.71399 |
[BP] GO:0009966 |
regulation of signal transduction
|
AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
2.68828 |
[BP] GO:0007165 |
signal transduction
|
AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HCAR2, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2 |
2.68641 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.6778 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APEX1, APP, AR, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, MAOB, MAP3K7, PDE5A, PPARA, RELA, TOP2A, TYR, XDH |
2.66671 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, HMGCR, MAP2K1, RELA |
2.65594 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
2.6458 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, MAOB, SRC |
2.64248 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, MAP2K1, PIM1, TNKS, TOP2A |
2.61985 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
APP, AR, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
2.58868 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HMGCR, HSD11B2, RELA, SRC, TYR |
2.58868 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.58077 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.57188 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CYP19A1, FDPS, HMGCR, HSD17B3, TYR |
2.55936 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
2.55936 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.55848 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.55489 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
FLT3, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.51342 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.50423 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TNKS |
2.49454 |
[BP] GO:0065007 |
biological regulation
|
ACHE, AKR1B1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.48764 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, RELA, SRC, TYR |
2.4792 |
[BP] GO:2000145 |
regulation of cell motility
|
APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.47112 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, MAOB |
2.47112 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, HMGCR, KDR, MAP2K1, PDE5A, PIM1, RELA, SRC |
2.47112 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.44537 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGES |
2.43674 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.41272 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.41272 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.40765 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, FDPS |
2.38764 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.38622 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, PTGES |
2.38264 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
APEX1, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HMGCR, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, XDH |
2.37732 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
CYP1A1, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, SRC |
2.35959 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, MAOA, MAOB |
2.3368 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MAP2K1, MET, PPARA, RELA, SRC, TNKS, TNKS2, TOP2A |
2.3368 |
[BP] GO:0009628 |
response to abiotic stimulus
|
AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HMGCR, HSD11B2, MMP2, PPARA, RELA, SRC, TYR |
2.32464 |
[BP] GO:0016042 |
lipid catabolic process
|
AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.32084 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, PPARA, PTGES |
2.32084 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, FUT7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A |
2.29716 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
APEX1, APP, AR, AURKB, BCL2, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, HCAR2, HMGCR, IGF1R, KDR, MAP2K1, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
2.28397 |
[BP] GO:0051338 |
regulation of transferase activity
|
APP, AURKB, CDC25B, FABP4, FLT3, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC, TNKS |
2.28397 |
[BP] GO:0042135 |
None
|
ACHE, MAOA, MAOB |
2.28397 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.28397 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, PPARA, RELA, SRC, TNKS, TNKS2, TOP2A |
2.26838 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.26396 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.23702 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22884 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.22156 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.20661 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PPARA, SRC, TOP2A |
2.20661 |
[BP] GO:0040012 |
regulation of locomotion
|
APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.20661 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.19424 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18081 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.18081 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.18081 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.18081 |
[BP] GO:0042592 |
homeostatic process
|
AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, ESR1, FABP3, FABP4, FLT3, MET, SRC |
2.18018 |
[BP] GO:0065009 |
regulation of molecular function
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, F3, FABP4, FLT3, HMGCR, IGF1R, MAP2K1, MAP3K7, MET, MMP9, PDE5A, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, XDH |
2.1719 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
APP, AR, BCL2, CDC25B, ESR1, F3, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
2.16667 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.15708 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
APP, AR, BCL2, CDC25B, FLT3, HMGCR, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, XDH |
2.15639 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2, MAOA, MAOB, PDE5A, SRC, XDH |
2.15639 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, HMGCR, KDR, MAP2K1, PDE5A, PIM1, PPARA, RELA, SRC, TNKS2, XDH |
2.15639 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.1477 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.13919 |
[BP] GO:0030334 |
regulation of cell migration
|
APEX1, APP, BCL2, CYP19A1, CYP1B1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.13438 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGES |
2.12836 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MAP2K1, MET, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A |
2.12432 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.1183 |
[BP] GO:1901575 |
None
|
ACHE, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, MAOA, MAOB, PDE5A, XDH |
2.11049 |
[BP] GO:0016125 |
None
|
APP, CYP19A1, CYP1B1, FDPS, HMGCR |
2.10962 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, HMGCR, HSD11B2, RELA, SRC, TYR |
2.10761 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.10422 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, RELA, SRC |
2.09672 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, KDR, SRC |
2.09672 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, MAOA, MAOB |
2.07246 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
APP, CDC25B, FABP4, FLT3, HMGCR, IGF1R, MAP2K1, MAP3K7, PDE5A, PTPN1, SRC |
2.07202 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.069 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MMP9, PTPN1, RELA, SRC |
2.069 |
[BP] GO:0050790 |
regulation of catalytic activity
|
APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, F3, FABP4, FLT3, HMGCR, IGF1R, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, SRC, TNKS, XDH |
2.06829 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.02536 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.01576 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.01576 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.01576 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.01576 |
[BP] GO:0031399 |
regulation of protein modification process
|
APP, AR, BCL2, CDC25B, FABP4, FLT3, HMGCR, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PDE5A, PTPN1, RELA, SRC, XDH |
2.01143 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MMP2, MMP9, PDE5A, PIM1, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.36014 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.35522 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SHBG, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.68928 |
[CC] GO:0005783 |
None
|
APEX1, APP, BCL2, CA4, CYP19A1, FLT3, GBA2, HMGCR, HSD17B3, KDR, MAP2K1, PTPN1, XDH |
2.55341 |
[CC] GO:0016020 |
membrane
|
ACHE, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F3, FLT3, FUT7, GBA2, GLO1, HCAR2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, SRC, TNKS, TNKS2, TYR |
2.43511 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTPN1 |
2.38264 |
[CC] GO:0043226 |
organelle
|
ACHE, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA4, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SHBG, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.18081 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES |
2.11686 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, AKR1B1, AKR1B10, APEX1, APP, AR, AURKB, BCL2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP4, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MMP2, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.0633 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TNKS, TYR, XDH |
12.7094 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
12.4208 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F3, FDPS, FLT3, FUT7, GBA2, GLO1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAOB, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PDE5A, PIM1, PTGES, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
12.4 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.9739 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, MAOB, TYR, XDH |
8.07384 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
7.39372 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.81973 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, PPARA, PTPN1, TNKS |
6.70593 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MAP3K7, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.66115 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, SHBG |
6.42495 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MAP3K7, MMP1, MMP2, MMP9, PDE5A, PIM1, PPARA, PTPN1, TNKS, TNKS2, TOP2A, TYR, XDH |
6.36315 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.3321 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.39454 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.14545 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.11122 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
5.11122 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.89299 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.74818 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.69066 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HMGCR, HSD11B2, HSD17B1, MAOB, PTGES, SRC, XDH |
4.46044 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG |
3.82053 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57745 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.47933 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.39278 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, MAOB, XDH |
3.35522 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MAOB, MAP3K7, MET, MMP9, RELA, TOP2A, TYR, XDH |
3.30776 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.30529 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
3.26184 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, PTGES, RELA, SRC, TOP2A, XDH |
3.19707 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.19707 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC, TOP2A |
3.00487 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.88489 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.7826 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.7826 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.76688 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.6579 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.6309 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.63054 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.58292 |
[MF] GO:0036094 |
small molecule binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SRC, TOP2A, XDH |
2.57805 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SRC, TOP2A, XDH |
2.49454 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, FLT3, HMGCR, HSD11B2, HSD17B1, IGF1R, KDR, MAOB, MAP2K1, MAP3K7, MET, PDE5A, PIM1, SRC, TOP2A, XDH |
2.49454 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
2.38264 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, AR, BCL2, ESR1, ESRRB, FLT3, PIM1, PPARA, RELA, SRC |
2.36113 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.3368 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.18081 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.18081 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, SRC |
2.10962 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP9, PPARA, PTPN1, RELA, SRC |
2.06059 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.01576 |